MARKET

MESO

MESO

Mesoblast
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.340
+0.290
+7.16%
Closed 19:35 03/30 EDT
OPEN
4.370
PREV CLOSE
4.050
HIGH
4.615
LOW
4.200
VOLUME
184.56K
TURNOVER
--
52 WEEK HIGH
10.88
52 WEEK LOW
3.120
MARKET CAP
462.89M
P/E (TTM)
-5.8451
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MESO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MESO stock price target is 14.00 with a high estimate of 23.00 and a low estimate of 5.50.

EPS

MESO News

More
  • Mesoblast up 8% on positive Revascor data
  • seekingalpha · 15h ago
  • CLINICAL OUTCOMES OF MESOBLASTS CELL THERAPY IN END-STAGE ISCHEMIC HEART FAILURE PRESENTED AT AMERICAN COLLEGE OF CARDIOLOGY VIRTUAL SCIENTIFIC SESSIONS
  • GlobeNewswire · 1d ago
  • FCAU, HLT among premarket losers
  • Seeking Alpha - Article · 03/19 13:23
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36

Industry

Biotechnology & Medical Research
+4.00%
Pharmaceuticals & Medical Research
+4.75%

Hot Stocks

Symbol
Price
%Change

About MESO

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
More

Webull offers kinds of Mesoblast limited (ADR) stock information, including NASDAQ:MESO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MESO stock news, and many more online research tools to help you make informed decisions.